Publications in collaboration with researchers from Università de Roma La Sapienza (11)

2022

  1. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism

    American Journal of Human Genetics, Vol. 109, Núm. 4, pp. 553-570

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Five insights from the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1135-1159

  2. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1160-1203

  3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1204-1222

  4. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1223-1249

  5. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    The Lancet, Vol. 396, Núm. 10258, pp. 1250-1284

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

  2. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease

    British Journal of Pharmacology, Vol. 167, Núm. 6, pp. 1311-1328